Piccina Cintia exercised Options for 20,000 Autolus Therapeutics plc shares at $2.35 per share on 2026-09-01, then sold 6,713 shares at $2.34 per share on 2026-09-02. The transactions left her with 13,287 shares and 60,000 derivative securities, giving investors updated ownership information.
Key Highlights
- Piccina Cintia owned 20,000 shares after the options exercise.
- The options exercise carried SEC transaction code M, while the share sale carried code S.
- Cintia held 60,000 derivative securities after the options transaction.
Autolus Therapeutics plc (NASDAQ: AUTL) executive Piccina Cintia exercised options covering 20,000 shares at $2.35 per share on 1 September 2026. The U.S. CCO and Country Gen Manager then sold 6,713 shares at $2.34 per share on 2 September 2026, leaving 13,287 shares after the sale.
Autolus Executive Reports Share and Derivative Holdings
Cintia’s options exercise used SEC transaction code M, and her ownership following that transaction stood at 20,000 shares. The filing also recorded the exercise of 20,000 derivative securities on 1 September 2026. Cintia’s derivative securities ownership following that exercise was 60,000. The subsequent sale of 6,713 Autolus Therapeutics plc shares carried SEC transaction code S and was completed at $2.34 per share. Her reported share ownership after the sale was 13,287.
FAQs
Q: What shares did Piccina Cintia exercise in Autolus Therapeutics?
A: Piccina Cintia exercised options for 20,000 Autolus Therapeutics plc shares at $2.35 per share on 1 September 2026. Her post-exercise ownership was 20,000 shares.
Q: How many Autolus shares did Piccina Cintia sell?
A: Cintia sold 6,713 Autolus Therapeutics plc shares at $2.34 per share on 2 September 2026. Her reported ownership afterward was 13,287 shares.
Q: How many derivative securities did Piccina Cintia own?
A: Piccina Cintia owned 60,000 Autolus Therapeutics plc derivative securities following the exercise of options for 20,000 derivative securities on 1 September 2026. The filing identifies the exercise with SEC transaction code M.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.